Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

VRAI Heart


C19, 19 cours Blaise Pascal
F-91000 Évry-Courcouronnes
Phone: 06 31 88 41 25
Mail: contact@vraiheart.com

Guilhem MAFFRE-BAUGÉ : président
Heni CHERNI : CTO
Mohanad MAHFOUD : Fondateurs
Site Web >
Vrai Heart-logo Vrai Heart-logo

#Diagnostics #Virtual Reality

  • Virtual reality
  • Artificial Intelligence
  • Cardiology
  • Electrophysiology
  • Visualization

Domaine d'activité


VRAI-Heart offers unprecedented intuitive, real-time navigation, enabling complete immersion in an extremely precise heart model, personalized for each patient, thanks to a combination of virtual reality and artificial intelligence.

BACKGROUND
VRAI-Heart was born in 2021 within Evry’s Genopole ecosystem. The project continued its development thanks to two programs: Genopole’s Shaker and Institut Imagine Biolaunchpad Entrepreneur, along with an incubation at Cluster C19. A cross-functional team gathered to create the company in June 2024. This was followed by a patent application in July of the same year. Since September, there have been a number of significant events demonstrating interest in the solution. VRAI-Heart first became a prizewinner in Genopole’s GENE.io program, then obtained the DEEPTech label from BPI France, and finally won the “Digital Start-up Trophy” from IMT Starterr.

DESCRIPTION OF PRODUCTS / SERVICES / TECHNOLOGY
VRAI-Heart is an AI-enhanced virtual reality and motion tracking medical device. It combines preoperative imaging (scans) and real time intraoperative data in order to offer intuitive navigation and more precise targeting thanks to immersive virtual reality, hence improving cardiac ablation procedures.

CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS
– 17/06/2024 Incorporation
– 11/07/2024 Patent filed
– 13/09/2024 Évry’s Genopole GENE.io laureate
– 01/10/2024 DeepTech label obtained from BPI France
– 14/11/2024 BPI France Deeptech grant obtained
– 10/12/2024 Winner Digital Start-up Trophy from IMT Starter

COLLABORATIONS SOUGHT 
– Experimentation-oriented hospital departments
– Motion tracking specialists
– 3D modeling and printing experts

  • FURTHER INFORMATION

    1 patent
    1 employee
    STRENGHTS
    Large growing market, high unmet medical need with high impact on public health ; experienced team. Unique solution, scalable and with high barriers to entry.
    INNOVATION ASSETS
    unique combination of digital twin 3D modeling, virtual reality and motion tracking

SHARE
Companies directory

#Diagnotics


In the same field

CGenetix - Entreprise génopolitaine

CGenetix

CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

Discover
EndoGene.Bio - Genopole's Company

EndoGene.Bio

Research & development for an in vitro diagnostic tool for endometriosis

Discover
SafeInsight - Entreprise génopolitaine

SafeInsight

SafeInsight seeks to provide a response to the growing concerns of consumers for the composition of the products they buy and accompanies manufacturers aiming to attentively circumscribe the problem of endocrine disruptors.

Discover
Floating Genes - entreprises génopolitaines

Floating Genes

Floating Genes develops diagnostic tools for use in liquid biopsies via the highly sensitive NGS detection of circulating tumor DNA.

Discover
Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Discover
Innovhem - Entreprise génopolitaine

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Discover
IntegraGen - Genopole's Company

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Discover
Enalees - Genopole Company 2024

Enalees

Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

Discover
View all >
With the support from
Région île de France